It remains unclear whether this phenomenon is an exception or whether it occurs in a certain number of cases, and whether diagnosis and treatment (in combination with) targeting somatostatin receptors would be beneficial for NEC with SSTR2 membrane expression requires further case accumulation. The gene discussed is SSTR2; the disease is neuroendocrine carcinoma.